DJ Biogen Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slipped 2.34% to $172.97 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.11% to 6,816.89 and Dow Jones Industrial Average falling 0.56% to 47,916.57.
This was the stock's second consecutive day of losses.
Biogen Inc. closed 14.54% below its 52-week high of $202.41, which the company reached on February 6th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 1.18% to $238.46, Pfizer Inc. $(PFE)$ fell 1.10% to $26.92, and AbbVie Inc. $(ABBV)$ fell 2.10% to $207.94.
Trading volume (1.5 M) eclipsed its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 10, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 10, 2026 17:01 ET (21:01 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.